ストックスクリーナーアプリを入手
82.92
0.59%
0.205
前日終値:
$82.72
開ける：
$82.93
24時間の取引高:
9,987
Relative Volume:
0.03
時価総額：
$1.89B
収益：
$923.71M
当期純損益:
$84.68M
株価収益率:
21.04
EPS:
3.9419
ネットキャッシュフロー:
$182.81M
1週間 パフォーマンス:
+3.59%
1か月 パフォーマンス:
+5.81%
6か月 パフォーマンス:
-1.37%
1年 パフォーマンス:
+43.98%
1日の値動き範囲:
$82.56
$83.75
1週間の範囲:
$80.67
$83.75
52週間の値動き範囲:
$57.33
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
名前
Ani Pharmaceuticals Inc
セクター
電話
(609) 759-1810
住所
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, MN
Compare ANIP vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
82.92 | 1.88B | 923.71M | 84.68M | 182.81M | 3.9419 |
TAK
Takeda Pharmaceutical Co Adr
|
15.94 | 51.34B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.305 | 41.15B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.23 | 39.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
80.47 | 34.09B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.66 | 24.13B | 3.17B | 1.29B | 1.01B | 27.09 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 開始されました | H.C. Wainwright | Buy |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-03-12 | 開始されました | JP Morgan | Overweight |
| 2024-12-11 | 開始されました | Leerink Partners | Outperform |
| 2024-10-11 | 開始されました | Piper Sandler | Overweight |
| 2024-03-15 | 開始されました | CapitalOne | Overweight |
| 2023-08-22 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2022-09-07 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-02 | 開始されました | Truist | Buy |
| 2020-05-07 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | 開始されました | Guggenheim | Buy |
| 2019-05-10 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | 繰り返されました | Canaccord Genuity | Buy |
| 2017-07-31 | 開始されました | Canaccord Genuity | Buy |
| 2017-02-22 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2016-06-23 | 開始されました | Raymond James | Strong Buy |
| 2016-05-24 | ダウングレード | Standpoint Research | Buy → Hold |
| 2015-11-13 | 開始されました | Standpoint Research | Buy |
| 2015-09-28 | アップグレード | ROTH Capital | Neutral → Buy |
| 2015-08-05 | 繰り返されました | Oppenheimer | Outperform |
| 2015-08-04 | 繰り返されました | ROTH Capital | Neutral |
| 2015-07-31 | 繰り返されました | Oppenheimer | Outperform |
| 2015-07-15 | 繰り返されました | ROTH Capital | Neutral |
| 2015-06-23 | 繰り返されました | Oppenheimer | Outperform |
| 2015-05-18 | 繰り返されました | ROTH Capital | Neutral |
| 2015-05-06 | 繰り返されました | Oppenheimer | Outperform |
| 2015-04-10 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2015-02-26 | 繰り返されました | ROTH Capital | Buy |
| 2015-02-18 | 繰り返されました | Oppenheimer | Outperform |
すべてを表示
Ani Pharmaceuticals Inc (ANIP) 最新ニュース
ANI Pharmaceuticals raises 2026 revenue outlook to $1.08B-$1.14B while launching $100M share repurchase program - MSN
ANI Pharmaceuticals, Inc. $ANIP Shares Sold by Lisanti Capital Growth LLC - MarketBeat
Precision Trading with Ani Pharmaceuticals Inc. (ANIP) Risk Zones - Stock Traders Daily
ANI Pharmaceuticals (ANIP) Q1 earnings: What to expect - MSN
ANI Pharmaceuticals (ANIP) Q1 2026 Earnings: Revenue Beat, Guidance, and Stock DropNews and Statistics - IndexBox
ANI Pharmaceuticals (NASDAQ: ANIP) investors back directors, pay and stock plan - Stock Titan
ANIP Stock Price, Quote & Chart | ANI PHARMACEUTICALS INC (NASDAQ:ANIP) - ChartMill
ANIP News | ANI PHARMACEUTICALS INC (NASDAQ:ANIP) - ChartMill
ANI Pharmaceuticals' (NASDAQ:ANIP) Earnings Are Weaker Than They Seem - Yahoo Finance
ANI Pharmaceuticals Q1 2026 earnings preview - MSN
Profitable Stocks: MYR Group & ANI Pharmaceuticals to Watch, B&G Foods to SellNews and Statistics - IndexBox
ANI Pharmaceuticals (ANIP) shares jump after earnings beat and higher outlook - MSN
How Raised 2026 Guidance And A New Buyback At ANI Pharmaceuticals (ANIP) Has Changed Its Investment Story - Yahoo Finance
ANI Pharmaceuticals Refocuses On Rare Disease As Buybacks And Insider Sales Rise - Yahoo Finance
UBS Group AG Has $11.90 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook - TradingView
ANIP Valuation: Does 9.8x Forward P/E Offer Upside? - TradingView
Ani Pharmaceuticals Insider Sold Shares Worth $1,127,120, According to a Recent SEC Filing - Moomoo
ANI Pharmaceuticals(ANIP.US) Officer Sells US$4.27 Million in Common Stock - Moomoo
Insider Sell: Ori Gutwerg Sells Shares of ANI Pharmaceuticals In - GuruFocus
ANI Pharmaceuticals director Walsh sells $1.13m in stock By Investing.com - Investing.com Canada
ANI Pharmaceuticals director Walsh sells $1.13m in stock - Investing.com
ANI Pharmaceuticals (NASDAQ: ANIP) director sells 13,973 shares in open-market trades - Stock Titan
Insider Sell: Meredith Cook Sells 500 Shares of ANI Pharmaceuticals Inc (ANIP) - GuruFocus
Ani Pharmaceuticals President & CEO Sold Shares Worth Over $4.2M - TradingView
[Form 4] ANI PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
ANI Pharmaceuticals (ANIP) CEO sells 55,000 shares at $77.57 average - Stock Titan
ANI Pharmaceuticals (ANIP) SVP sells 2,772 common shares - Stock Titan
ANI Pharmaceuticals (ANIP) legal chief sells 500 shares under 10b5-1 plan - Stock Titan
ANI Pharmaceuticals (ANIP) is a Top-Ranked Momentum Stock: Should You Buy? - sharewise.com
[144] ANI PHARMACEUTICALS INC SEC Filing - Stock Titan
ANI Pharmaceuticals Announces May 2026 Investor Presentation Highlighting Generics Growth and U.S. Manufacturing Footprint - Minichart
ANI Pharmaceuticals Updates Investor Presentation, Highlights Non-GAAP Metrics - TipRanks
ANI Pharmaceuticals projects ~$1.1B 2026 revenue; raises guidance, $100M buyback authorized - TradingView
ANI Pharmaceuticals (NASDAQ: ANIP) targets ~$1.1B in 2026 revenue - Stock Titan
ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Vanguard Group Inc. - MarketBeat
Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 Million - Yahoo Finance
Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 Million - The Motley Fool
Patrick Walsh plans sale of 3,973 ANIP shares (NASDAQ: ANIP) - Stock Titan
ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised - The Globe and Mail
Zacks.com featured highlights include ANI, Cummins and Seadrill - Yahoo Finance
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Perkins Discovery Fund's ANI Pharmaceuticals Inc(ANIP) Holding History - GuruFocus
Is ANI Pharmaceuticals (ANIP) Still Attractively Priced After Recent Pipeline Developments? - Yahoo Finance
ANI Pharmaceuticals Inc (ANIP) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
ANI Pharmaceuticals (NASDAQ:ANIP) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
MSN Money - MSN
ANI Pharma Q1 2026 slides: rare disease shift drives 20% revenue surge By Investing.com - Investing.com South Africa
ANI Pharma Q1 2026 slides: rare disease shift drives 20% revenue surge - Investing.com Nigeria
ANI Pharmaceuticals, Inc. (ANIP): A Small Cap Value Stock Capitalizing on Generic Drugs Opportunities - Insider Monkey
ANI Pharmaceuticals (NASDAQ:ANIP) Issues Earnings Results - MarketBeat
Ani Pharmaceuticals Inc (ANIP) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.89%
大文字化:
|
ボリューム (24 時間):